[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "What is the binding affinity of 7-dimethylphosphoryl-3-[2-[[(3~{S})-6,6-dimethylpiperidin-3-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]-1~{H}-indole-6-carbonitrile to Cyclin-dependent kinase 7?\n\nAnswer Choices:\nA. < 0.1 nM\nB. 0.1 - 100 nM\nC. 0.1 - 100 uM\nD. 0.1 - 100 mM\nE. > 100 mM"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208490-2uaNa0L5RZEP0TwY0CYO",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"B. 0.1 - 100 nM\",\"answer_letter\":\"B\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Determining binding affinity**\n\nI need to determine the binding affinity of a specific compound to CDK7. The compound seems to be THZ1 or possibly \"Samuraciclib.\" I\u2019m parsing through its complex name, and could it be \"SNS-032\" or \"ICEC0942\"? Importantly, I'm considering the affinity ranges: <0.1 nM, 0.1-100 nM, and others. I suspect the potent kinase inhibitors usually fall into the nM range, so I'll opt for B and finalize the JSON with that choice and a concise justification.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Determining binding affinity**\n\nI need to determine the binding affinity of a specific compound to CDK7. The compound seems to be THZ1 or possibly \"Samuraciclib.\" I\u2019m parsing through its complex name, and could it be \"SNS-032\" or \"ICEC0942\"? Importantly, I'm considering the affinity ranges: <0.1 nM, 0.1-100 nM, and others. I suspect the potent kinase inhibitors usually fall into the nM range, so I'll opt for B and finalize the JSON with that choice and a concise justification.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSr0OPHi4LQJ4xkHGvr7pLp3CvGAzncpeLIxWgYuH3JUgswokmVM0VxIEn50zBIg2vtkquLWFddimXxdO3jMYR-e7WkWDbd8a3fWVDuGITo9IVCQvDVtyAxqnazNBXW7Q3dLnTszf8Z9JepfH4poxW5VLkTdddEYwIGwfba7wmZF06R_WuSjS6uW_KqZId2JKaj5jiyUApj3qrxObZ4RhJKf6WAv5Ggh2HZA_AHyJHOyzJDmWhFnH7VGew262SQAvwe4B2qW43JbLzmB_ppkSriUgYwMRsKa0-3yXNIqQOcrIB8ICTX7vIrRjg76ZLc8LgSD-kF4N9r3WIl66EQOAjswMbAtVzrpFc91cDx2PxKI9bd2eYZALYN_-2px-9agz9g7EtpMfZWqZJCgIqddZzw3EiBl8oA0Vj8NjMZJVO6hFpcG-SUwD4Nvcrf0p7oaOTwQhMrNSbwAPxGjUkN6seMQzNoh58R5S4V0F3lw4X4AmIEKpkzPZQxVBx9N-dPQHlNPUisyPUb4BKym_dYMmpADTLlx12PWMd3KyJqOkQ97uowFPUvauZDjipBKVuX0O-HBBhMNGsbIBr6WYuJHERU133wEVSNn3Smdh9C8p9k8hPVL58LSG8YO-C3hCURG6omV_wEuZtpiQUt1O9tsMFmHfx6VXFET0bDpAl-D44hf6j_VaSS5_vCAnge_PkCSS1e305baiDBJzJKs4QLeYqU8IOajheZVCgPNO_HZjtiBUPIqZz2Swc9bLF_NQQAWlQ3iXbAGDYIESzR7hTenBQoF5lLRMnBFrAAsvFnIuSP5BppMLndGVNV8BnCd9oBbDdezNQ6BwU1ntlIrS6AtmqLu9gvmCxUwEfM7vTdfA5D-TnG_6Xof1R6varzN33qr17XNuQc4LCTZkm5zsNQCMtOYMJioBrJiODTiezl2IMIW3ivVnYmUFxhug3LNKuShL3B3lcDtztKe2_JSBcOiUeGce1_exjzdXx-XuER9VEm4PHzRH_XHfJW5Hl52DWAz9vkAojk9LXzJR7yxOlc3Ig59w-TcuUQbjLBpWYzwZlAu7K1zpbM_VLLqArkttqVTqFXbBVrW_y1xlUqMGaK_rkFCl_jMSUmVEpkMusPZB9zEYBwe9akwh02CB-zvhBKFV289fRocH0O2wzX1c2-LXTzY_E4mXTbJI1s1JNvXrIOj8WtAY3zXldnSB5Dsj_A50M32iTMWt8y0psQpjJzSiD31Y5QVKbGVvg1XTTnkIrx2--o9zlCvXshIUcLliSNjKJVpC0Id1IE0rxOfdeFJbtgiFPkrUYLpbioTaOtW98XrUiYDTCIxgFyENomgWWmgknCTNmW1ZKp3eyX7-BI7pXskX0r9fJ-HvYGAOBMKh6Cg1dc-uPPtminKX3IPMw40r5lriXesR23ryfNYXKgDimmj0jRmrtOg8N-GkQljlq6TXsy93D-J41SgjJA-TAmVxfGMhcspmwEixs3UshPkR5tBsBRkPNB1xFaSuFtotx2zye4ta1n7YC_E4KUwSRZMRLONALeYexfuUQlH1dhAtg8WvRkk5Cg2nOUyUfC1c_3nZHerEWCRVWqDb4NDfo_j_FoS2wPIirQ6-X2xo6zLDzAOfXUznlyWtDQ7fxKpcARPJTw5tVbIN8XzyiftF5qg_1GQAGBLeIx4U9pVd7059rfmxFsy89-VUzCnXo6r6Hedyq4BPbEPdIyz--vIrH7vfC87taHx_06nTN-EkMeVlUnqMmwWs6KhGb28WjRHRBSOG1ECoLg62C6zhJa9P-pnBozosvNdDrMgGEGOLAetWa_Nnm8iBOhaFYjzq-jyNkp1O2EgB-aodr-GlG0ktTzngcPy_5Ht4BY1RfD0yuuXuT6wEr92KrirV5rH-uE7bVsIYhEtATHorllT8WmuaOeH8WI_0aBjkmWiYHiP4O8qCdLSBunt-Pm6EJ5U1LMKV_a3qTLENh2q_Ow3A0J1wvN4t1wN7j5C9eSTZxLsQMaqiqX8xHwUrlVkB63XX6purTVk-MRRoSJ2AZf2KzVKUvzoiRQy0O8MiIakYI2Q2z0BlJyp8K-LHdxTc9TzcDMBAtDceHjV7UybBfIEy1eRDr6muCsWMJpFbYbBPGE9-TpNTIBSVPsl8XRmqied_x6sO2khQSN9PbCXy5ub9n3PD6OUG2sGvQchNWTdPc1YtMffaFDCLyRrX9KykRAx3XLu1g8bl4gIVq4mlgpx0ORZkAKOq0z4uYtsNZ3BdD7ICVeRUysxMgtVUa0AsnoAGh13qdhujoXFYzKPWjjsAhScH79ZkA_q8fN9Y2-YT_NVaj_qgoO7qcbPT6CNQnnFfBxc0D09QBgMp6a375vUfXnyTt5BlCiD9jw4or2Y4OZWlRMSfTZ1ew==",
                "id": "rs_006e5550f90901640169092aeb31e4819088ee5146b5b45a70",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208490,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 349,
        "prompt_tokens": 185,
        "total_tokens": 534,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 320,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00074425,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 4.625e-05,
          "upstream_inference_completions_cost": 0.000698
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "What is the binding affinity of 7-dimethylphosphoryl-3-[2-[[(3~{S})-6,6-dimethylpiperidin-3-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]-1~{H}-indole-6-carbonitrile to Cyclin-dependent kinase 7?\n\nAnswer Choices:\nA. < 0.1 nM\nB. 0.1 - 100 nM\nC. 0.1 - 100 uM\nD. 0.1 - 100 mM\nE. > 100 mM"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208490-71flNjuhmoV7d4b2JXdf",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"B. 0.1 - 100 nM\\n\\nThis compound (commonly known as THZ1) is a potent CDK7 inhibitor with low\u2011nanomolar binding/IC50 values.\",\"answer_letter\":\"B\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Evaluating compound affinity**\n\nThe user is asking about the binding affinity of a compound to CDK7. It seems like they're referencing data from sources like BindingDB or ChEMBL. The compound has a complex name, and I notice there's some unusual formatting with the symbols. It looks a lot like THZ1, which is a covalent inhibitor of CDK7 with an IC50 of about 3.2 nM. I suspect there's a typo in the user's compound name where it says \"7-dimethylphosphoryl.\" I'll need to clarify that.**Determining binding affinity range**\n\nI\u2019m assessing the binding affinities, which are organized into ranges: <0.1 nM, 0.1-100 nM, 0.1-100 \u03bcM, 0.1-100 mM, and >100 mM. It seems the relevant range here is 0.1-100 nM (option B) given its context as a known CDK7 inhibitor like THZ1, which has low nanomolar potency. So, I would conclude that the binding affinity falls within 0.1-100 nM and answer with letter B, keeping it concise.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Evaluating compound affinity**\n\nThe user is asking about the binding affinity of a compound to CDK7. It seems like they're referencing data from sources like BindingDB or ChEMBL. The compound has a complex name, and I notice there's some unusual formatting with the symbols. It looks a lot like THZ1, which is a covalent inhibitor of CDK7 with an IC50 of about 3.2 nM. I suspect there's a typo in the user's compound name where it says \"7-dimethylphosphoryl.\" I'll need to clarify that.**Determining binding affinity range**\n\nI\u2019m assessing the binding affinities, which are organized into ranges: <0.1 nM, 0.1-100 nM, 0.1-100 \u03bcM, 0.1-100 mM, and >100 mM. It seems the relevant range here is 0.1-100 nM (option B) given its context as a known CDK7 inhibitor like THZ1, which has low nanomolar potency. So, I would conclude that the binding affinity falls within 0.1-100 nM and answer with letter B, keeping it concise.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSr5xQtR0xIfc1OsAVVZ3G-XFj3VMx51M_n4uHW1yUmz_10zUwVhHMaA3b1mcmuWy4tVx1hjUIbw6toljSZYdJPAT6zsTvafvUQ5kh-ijb3fN-LQOGQvdA2lwR6XUh19PXZ_R0tBiDgOAF-quKycJZ6gsmJeF_ayyiLwsgZV_gSd2eQ7-Gtp4AweTOImj2I2JSddqlXQGDijtLIXU9145GVg9I4OpaY5Idembg1NnfnIn1zEV4wLwI4rQR5BTyo315RdkO66cqc2ao5dGxUii8zraD4V4V23nQYFoYS7o5kP3yVeTBOFd1HmCwmrAWdhKwVSCVAGeMGrM1jErksAvjpqbrE6CYSEZUu5_tyUdJ8EfFFWmwJ_pEH0nKY8RY8mRQZoDLPXuJKy5J0GJrKqH-mfsC4Du_IAA5S1Mn8Dbc5k6XpGbpH41GFDOf3fZiRtbsUwYiQ14zOAVNTmzvzRUEWnwD-r23eQfP8UytFH8E0laQlnWCC8y0J1uxlEbGr8yrmAQAvCGPAzd-SWGvq7sYMdPkyNExcupR6jEv8Kkm_H1-j36FaIfcv-BXirOgARCE36Z8zR3u5vNeVHfEP6-yedtEdgzWs2A2rYtkiakE3gQd_bs6w2OL2r68hWPjON3gWjP0edu5C9eqIYP5FtGdVA8B7zBj9RWMKn2qjjRfWhcmHZbNyr_SZ7yDXEgsEXiggKb2FYNa_2IHL2EQrkDSO74Rbhk19pvMToRIPUiTaD6XMe-XwOxUa96PvIp5fQ2HUPJufNecbZTkuiX8XrQJNnuDYBQXpQ6CJ1QITPpvMorizJ6fV6NR1huVPv8sB-q6-XgRwr9_a84GJTUrlc3u9E-upX63dx9HGcGwhpgQR0JLOiZ6OPBxHI-bpT2zWsFr_Cas596gZlZlz74YZNmvyqqS9jZY4_RkGBtjKGM6DEVXqw-KqYDW_wQKjbIAYFjLrxihXkpSGzNPjO1gSO9iDM9yul_K_JBKXKDkE9JvGJR5cgu7gElhxMg0VPpLgb6tFIAzWh9qlLArsLJ8mR_dkh4LOtK7s0yvKS0IvxvdZ0DG3TTEuN0cFg4rgaC0vrhW2jQl-Ydy1LmysKyDiEhjYSxf79KVQ7tpM2B4XNCjjK4avBgZZ7UUuqCDYnLDYLxbb8LapXsh-ehmmosGMxYprNStmcS-qwAdVUqRA-PVm2-edoflLEqbMpXvsglfHTiJwdmrYTeBRCiRMXCipuvkj3ZFQCS6ti0vCZUpgHespEeDKaj2tW8eJTDxLNicGNZG9CkIp-QZn_0qBHaECOOixk0WMm_r-dmjGsLBC9sYV0fd0zVRy2BMVQNJdyD2LvG0Qt4f63HD9yj8CMhbIhp3CnreIW7Bu94cBZobFsFpwg-_Ghb3Yf0UlBOCc7v8Uk0ZYemIgn-eJsXqbVP7Y6gsv8hFk9oZ1JYnVLHzGuA6ppYjh_srJ-mWu9AT-VEB5FXW3VbPVIQN8RD0LkiMrsZ7rva5N8HkJdLaz8lPtRY1kk4-0XxrVwaBrIc7fwyzIrfSSAylcrntdgBLKCQFvVbLMC-35-1N9TkfgqI4SGU-EkCboIaNpwWdco8VupaWacDU3vnYsAW3yA0liGnGUT67hJ2tOe7tcCbJCxcL2ElUBjg9Gj71Zn-k9RXPGMpHa7hVkSy5HnyqlCtmaQevLUIiadTgwgV2ThaSBaCBfovehcfJ0OeV_ozXxXkmHklp9SXTpqngHMGgcvwfj1sXILD4slDhXLNhgTPWtOS1dUIdyEmevGiLD0sMBJZ3B1WXmM22ETDKyU7r8N7LpjuAqtih5Ozbf3_pr5mLTjvlNSvU0dxT05OmsklYkjEsc6kb0CpRoKm9HO1O_LpkcP2dX5KcvLfz2xc6OPJUHvnLTgagIajzG2dnKAJyeq0kY7sxeseI-Wth85FXFHCxJQU-Vul2r_Qf89v3ovfKFNpKP339XBFUGseJ_6pH6bXy8t7bZPzx4W4MTUGaRy7CepAOXbNUhrrtmyAytlw9Y2L0_q63NoceaPg30nMZqfsKN-bZCXK0HQDzSupQde7_OoxWLbgFetk6RLP5I4U3xXaTXCLuZn5-1QqeCU-1uwqUDOVY-n0B67qDLGWKBj4sbGoRAAJV3xNUmfxVyg8iaHH9hesLkro4gu51dMq43Bf1K-XISdc6u-tmQPRF2wzvWHJmLPQhOWrnDFNoUKFMG--kgr2aTj2aYJtHfu2bZkQ8L9vJ6kcqZgPYmB1llciGcNQZRz-C0jLR8YhfRS9Ef3_41d0PxrB_90a49c932stDarfjymjmMe7K5ockCFVfb7OK7DQtBiRJklxVWQWmwLWSx9oWiQJ1gaX85QWIRIMfMz84aVN79lCva-Ld7nn8wLZ007Sa1iaxuPEqZBrSfe63tkZH1-emVZD0RNPIgSEbJ9oA2tNVeBSNYB3ybFxzjUly2aGkejl9FzYHQb3TUrfPrv4cSf6_5Zxc_9zRlVSGqnlGqUU9JVpnmTYO1RFJSiXw2a72QWAv3DNoH8uhpuR3JY7cPiNZ12b-_03aOONPrmTvaPSEWdmhN4qSRs3J4a2eJv1YLvv0WXwW6IrDAv24QEBlX2IVvYGw1qY2YJLuqa-mosHDhLlVHEKv25V0us_dfQPg7QZRjmNiWiTaYMi8nB9eli3bBex_Ay6i3DaVbFP7SJmatBr_9M51ofvdX9-iK_kj9AmZbQCR066r4bsFI5L6KLbs6defO4k1oClayWbyy2rNk4iLlWbsiepzWiFqFDM9VvuAGqVaK1gbV4BXqjsP-OuyIN5ATmIcOX9O0XckcpWVW1317fjxAfaUuEVxLiGLIx1nZE6PupNtr4bENBBrQrcwCDYTNdP85hzYZV1Zv6kz4EdWCZUdoPZA_ZcLumvq13EY7HwpDGZdRWj9VoRwjq52CL_UvmX3fZw7Yjlw2jCl0Q-aE5LFbgPwcgwzSo4gu-rTQKWcw5hBVQ20DtSCgGqiDnFmzWxORk421EWx8vejA6",
                "id": "rs_0bc5f2578cdc361b0169092aeae0b88190a6f73a7a69326429",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208490,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 572,
        "prompt_tokens": 185,
        "total_tokens": 757,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 512,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00119025,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 4.625e-05,
          "upstream_inference_completions_cost": 0.001144
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "What is the binding affinity of 7-dimethylphosphoryl-3-[2-[[(3~{S})-6,6-dimethylpiperidin-3-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]-1~{H}-indole-6-carbonitrile to Cyclin-dependent kinase 7?\n\nAnswer Choices:\nA. < 0.1 nM\nB. 0.1 - 100 nM\nC. 0.1 - 100 uM\nD. 0.1 - 100 mM\nE. > 100 mM"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208490-dmDjBVX1TpoZSZbVIkoN",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"B. 0.1 - 100 nM\",\"answer_letter\":\"B\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": null,
            "reasoning_details": [
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSr0iFEz8BBQmnvl56HWEeeZw3JvGObjTQeQmi4S5uzIC8S3W3ks2OldJZO2TsiKmVK4hFwAfZwOIx7q739msNXYUCLc1mUwSx1oMFBDU8VnuY--xpJ-x6svFvUCuKTeJTriUYTQuzIC_rzQWSP9LL_4mboin9N1YqHBAsYoKlgqUhNCalR6pwXd2kXo_VH7-Gqn_w2jf_X0IClN9KgYwaEl6sFTgaZZn2ZQF6CT0GNyNFxr6WD4DgIpFkQMHkbB2U6Z2sshBlRH01lyglL48skE_IJEgmSokJslDtT1RcqkuJaPDaM0d7P3ji2KoSJes6aKaXGa1LicykzwU3Y8rCguOfVoa-5Kw4c_wHVzp6LY9z0x71jpcxrnqPkBonPEINC9sAX7TItn3F5BIKhdwp9ASIMIPDdSjmfWGX6wIobjx3bLkbDdomcxizkFTwoJp48WRGxeZmoWC_WRlldupdzrdsy-o37cdSxb5u9thMVaBuzlBe36WE4ZVkrUbZGhu4VF01mmysc1JOk7KziFrqV44i4l-jotJRMX30dWApRQi3TP8AfM_6qC8TjDd7rHqnFVPiV_nPHugFnVz-YnKkqFIL2V3h4uOQiFQYsQrmVwpYPiMZMiGaiMy1nwuovzzz8NebHJMY7qokVJ0CJhf1d9OVOEcJP5twJYGURTCeKx0f2T8zzeIwRq7jDz40FKm7TEqfx1HVvNWQuMhgF5Vw1CovgjyCdr5P2yFlkHO2WpGHTuMXAOpIEfGaAqJw0rNRBVSQisvQ77oRjT_xMI0X3ZGxP9Vx3Xd0YSPRSUTby-Lz8Mh6SlOQrGf4qzOmv-qbG0ABSlxLnYU8boB658Oev_OEKat7NOJ0ycBClwL4CEgAgA15gPIu8j4tA-Opzd7GHuu2n0y3QMq5nnlZNkRW5prinJzGveTQlITfH5b2WH9BDYz4_Dzumx5Bzv3F72S8fEbL0XP_ZBfipL0xUw5pgDPWQaZH_-pKQMx5NaSN_gHMYLmIXTc8xYINq5IzWCxPPssWguMkJ5U9OaHHxLaHYBEerh-72OriffbCDzr559U3mn5ZEBmfVNiIzQbQqRrBFYGMzS2lE2jqAbWG2J6sOZpFelATqj-mREcZzgmBLnyauSYFF3WaRVxquQgF41rQLywlFILCBId_AcZ9p8bpDoLXY0hNRE_M5Wxt3TBhQzAxzTkPi9-QknUrKuUPYPGTUodiBkAaXv6smZ0gfDD2LXqvmwv6g4H0Rb6QtOYd91VUGHpXnO8054EjXAZ97TYILF68iJYVjuCRr891HL0fYZ_7yxg2uzRg-4Z-BqFpFbP_DLnbXx7HxWxv6RRt9EKWjZ-RyV2QyUZLerZjlGAGkYuIWpxcWVkN2gTmGDhiXIITAB9Re_wjtI-IAJmNNXwyoc8JCh_6wtV-2w10nhuqLdicoP_zDBuFuynToKlLHLzPPGXqpAv9puG-vk22CENhsAeOS0aPmPwHdDoom5nE7p5EaVEQ4ZxMZi_sdEPrmOiWblOW46PFRvxQEm2ZEL65HeDqrsoOvwWMj6MqUQzEJJMh6L03XpESl2Bsl62C0aB1pNOHJ2SnEoSbBZFirnaDVtX9w14hMkdZwckijhMlZ0d0K4kuIr0rVEXmBixdJft0pb6SZYqVbw93fnHQ9CX12faANc7tjZUCSa1iDKHylwgWbhxYWvDciBTpp9ttayLcscoN2aRGoCfE2W48WRK9tghuHiS7je8MaIcZfOFSSmL3s-4ydhUFFwQcuK75np_RI7p-sDg3r2corOXAfTyhiZVh5Bp1jyQvxyQ-fGp6IPheDsfI-957IGiAnimCRjDYkZvfwE9TMsps9FY9LXeoqidRAu9_dzs0KchmRmUWXadRuYp_wKRw8RlRY54FSg1DakhWBS93skCHzoupjualeGrpLbVElSB8H4keRSL7V-3RSvXA--JXXuiLewAhEtlSrMH-plnC6K8vxIVvEj08GmL88mcnfzNkQlnR7Bl47ah6OX22Ewx8d8YxyDnEm8jNu3UU5ui_ZOY1PTbb44Lk0KAUFFU6lJxuhUT8AnykilpGlHcEI2jx34I0E3gFtNC9obgP1IYnRlmnT-IduoUqs7E9qKiVuSv7-d88QMiD9SW2CCTpah4kvS0AE0ChCWrNLW3RNHmMomhUJ8O5skK5GKzvOgkvYpocUBmAEfaYERUtRMCVA644YTcMRGZBhg6_kenKLj6DQJVfjJfa48ApeO2d-idv1WppbDiPg1ZlpWKpjeK1pDzLl0wWKokZdY8SBywRLQ5dYGsy5dZRtWodBbkyuDkhc0sdNbF9_KilcaBRlzFs68chZYg1bHlNFq71O2cB7BGJvad99H4NaBYY-GxwIsmyNF29wrZuYVPryYkGkC9MPqLk7vE29RczKzrQFeqiuV0s47Jq5LWujNmoSHyo9Vx8dNTqAlHD_MI9Kt_ZIU-_Sy7gX9EWCAMrQmrBuJ9AzOeX8z8XdDA6msUttE1_tJGnh0vsY9mdLCdlvkmfPmC048c9HyKGX5JByWEIbdvbRBgTiZvenEcdVMk2zX4X692hId9UG1wNDVrs_sZffw1nbb6mivOQKHNG7L0EV47_bauTcZBlxYCyjaDMJg29DOsg63lngdEQfPZ4k3XjCDfyJKkJLU65XjoyjMepbQooU2ioDqO4jYmjpuUeh9iYMVQ8pNfiIjzJqlnR7d7skEoaaX3751sZcVZCjGE332UKxTzU9UE7ifiZG7o0M8MNmDV1vKiOVb0Ks55YIgKuIJMjNGqzk86waJ2f8MGIt27xpMIiEVFH1E8kUwQx3QWV47uAq_ePJIleqM-1i1m9esydPWntgq6FUshliqYKxTV0BDwjqPco_g16Ul8E3sXqpwe2CtlBVZY3c99m9vD3T5oHiW1u5ZJU0xB1sZMXNoKxVUAuTKAtGndK4NS_uuJPaCCEanqiKaZnjzNIA2jWIpesV5UiIDMDjoAN72ry5s9G4vQ8fVsnjbbUQRtrdl1Oovheg9J9_aKxSqpSJ_Kzs_XcFyjzXU62J9RudZtQPOT8lrRKONjFKZd5TFyf_9A_D723Id9Hv5eLDTPUR-mMZC77cGmkTrHgVRTVy3C-tQj7kSgZDkC5KHvb0a1kUFRQp5uWutoRtb47hl8SIeNuHw70fL_83QG8sZt2MVl8TAfN6iCIWLbK3NWQPlkwSncz_ltYGTw_kPxXpiypm2Ey2OwpKTltaoYThf1g7CquTB21joHXXOBvOIF_aN3YoOiapybe3rbGxRdDz8QajfIw==",
                "id": "rs_0837c2ff337a1d130169092aeae0f08190b3eb8cd2d641dd5c",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208490,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 541,
        "prompt_tokens": 185,
        "total_tokens": 726,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 512,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00112825,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 4.625e-05,
          "upstream_inference_completions_cost": 0.001082
        }
      },
      "provider": "OpenAI"
    }
  }
]